✦ LIBER ✦

Whole-cell vaccines in phase I trial for cancer therapy

✍ Scribed by Carol Featherstone

Book ID: 118553032
Publisher: The Lancet
Year: 1996
Tongue: English
Weight: 28 KB
Volume: 348
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)66122-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor based cancer vac

Epidermal growth factor based cancer vaccine for non-small cell lung cancer therapy: report from a phase I scale up trial

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Generation of dendritic cell-based vacci

Generation of dendritic cell-based vaccines for cancer therapy

✍ Reinhard, G; Märten, A; Kiske, S M; Feil, F; Bieber, T; Schmidt-Wolf, I G H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 93 KB

Phase I clinical trial of survivin-deriv

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

✍ Akihiro Miyazaki; Junichi Kobayashi; Toshihiko Torigoe; Yoshihiko Hirohashi; Tak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

Hybrid cell vaccination for cancer immun

Hybrid cell vaccination for cancer immune therapy: First clinical trial with metastatic melanoma

✍ Uwe Trefzer; Guido Weingart; Yingwen Chen; Gunda Herberth; Karin Adrian; Helmut 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 364 KB 👁 2 views

Hybrid cell vaccination is a new cancer immune therapy approach that aims at recruiting T cell help for the induction of tumour specific cytolytic immunity. The vaccines are generated by fusion of the patients' tumour cells with allogeneic MHC class II bearing cells to combine the tumour's antigenic

Safety and immunogenicity of an oral, in

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

✍ R. McKenzie; R.I. Walker; G.S. Nabors; L.L. Van De Verg; C. Carpenter; G. Gomes; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 423 KB

A phase I trial of idiotypic vaccination

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer

✍ Steve Nicholson; C. C. Bomphray; H. Thomas; A. McIndoe; D. Barton; M. Gore; Andr 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 238 KB